SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Credit Suisse AG – ‘FWP’ on 3/7/23 re: Credit Suisse AG

On:  Tuesday, 3/7/23, at 5:51pm ET   ·   As of:  3/8/23   ·   Accession #:  950103-23-3804   ·   File #:  333-238458-02

Previous ‘FWP’:  ‘FWP’ on 3/8/23   ·   Latest ‘FWP’:  This Filing   ·   1 Reference:  To:  Credit Suisse AG – ‘424B2’ on 3/7/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/08/23  Credit Suisse AG                  FWP         3/07/23    1:45K  Credit Suisse AG                  Davis Polk & … LLP 01/FA

Free-Writing Prospectus   —   Rule 163 / 433

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: FWP         Free-Writing Prospectus                             HTML     39K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Filed pursuant to Rule 433

Registration Statement No. 333-238458-02

FINANCIAL PRODUCTS

FACTSHEET (K2230)

 
 

Absolute Return Buffered Accelerated Securities

Linked to the Performance of the S&P 500® Index

Offering Period: March 7, 2023March 30, 2023

Summary Product Terms

CUSIP 22553QRT6
Issuer Credit Suisse AG (London branch)
Principal Amount $1,000 per security
Term 15 months
Trade Date March 31, 2023
Settlement Date April 7, 2023
Valuation Date June 28, 2024
Maturity Date July 8, 2024
Underlying S&P 500® Index
Initial Level The closing level of the Underlying on the Trade Date
Final Level The closing level of the Underlying on the Valuation Date
Underlying Return (Final Level – Initial Level) / Initial Level
Upside Participation Rate Expected to be 200% (to be determined on the Trade Date)
Maximum Return Expected to be at least 14% (to be determined on the Trade Date)
Buffer Level Approximately 85% of the Initial Level
Buffer Amount Expected to be 15% (to be determined on the Trade Date)

Hypothetical Redemption Amounts

 

*The hypothetical Redemption Amounts set forth below are for illustrative purposes only and may not be the actual returns applicable to you. They assume (i) an Upside Participation rate of 200%, (ii) a Maximum Return of 14%, (iii) a Buffer Level of 85% and (iv) a Buffer Amount of 15%. The numbers appearing in the table have been rounded for ease of analysis.

 

Underlying Return of Lowest Performing Underlying Return on the Securities* Redemption Amount per $1,000 Principal Amount
50% 14% $1,140
40% 14% $1,140
30% 14% $1,140
20% 14% $1,140
10% 14% $1,140
7% 14% $1,140
5% 10% $1,100
2.50% 5% $1,050
0% 0% $1,000
−5% 5% $1,050
−10% 10% $1,100
−15% 15% $1,150
−16% −1% $990
−20% −5% $950
−30% −15% $850
−40% −25% $750
−50% −35% $650

 

Payoff Description

 

Redemption Amount at maturity

If, on the Valuation Date, the Underlying closes at or above the Initial Level, you will receive the Principal Amount plus a return based on the leveraged upside performance of the Underlying, subject to the Maximum Return.

 

If the Underlying closes below the Initial Level and at or above the Buffer Level, you will receive the Principal Amount multiplied by the sum of one plus the absolute value of the Underlying Return.

 

However, if the Underlying closes below the Buffer Level, you will be exposed to any depreciation in the Underlying from the Initial Level to the Final Level beyond the Buffer Level. You could lose up to $850 per Principal Amount.

 

Any payment on the securities is subject to our ability to pay our obligations as they become due.

Final terms will be determined on the Trade Date and will be provided in the pricing supplement. The actual Upside Participation Rate and Maximum Return will not be lower than the rate displayed in this document and the Buffer Level will not be greater than the level set forth herein. Please see the accompanying preliminary pricing supplement for more information.

      

 C: 

 

 

Selected Risk Considerations

The risks set forth below are only intended as summaries of some of the risks relating to an investment in the securities. Prior to investing in the securities, you should, in particular, review the “Selected Risk Considerations” section herein, the “Selected Risk Considerations” section in the preliminary pricing supplement and the “Risk Factors” section in the product supplement, which set forth risks related to an investment in the securities.

 

·Risks Relating to the Securities Generally
oIf the Final Level is less than the Buffer Level, you will lose 1% of your principal for each 1% decline from the Initial Level to the Final Level beyond the Buffer Level. You could lose up to $850 per $1,000 principal amount of securities. Regardless of the amount of any payment you receive on the securities, your actual yield may be different in real value terms.
oThe value of the securities and the payment of any amount due on the securities are subject to the credit risk of Credit Suisse.
oThe securities do not pay interest.
oRegardless of the appreciation in the level of the Underlying, which may be significant, the maximum Redemption Amount for each $1,000 principal amount of securities will not exceed $1,000 multiplied by the sum of one plus the Maximum Return.
oIf the Final Level is less than the Initial Level but equal to or greater than the Buffer Level, the Redemption Amount will be subject to an embedded cap.
oThe probability that the Final Level will be less than the Buffer Level will depend on the volatility of the Underlying.
oThe Redemption Amount will be less than the principal amount of securities if the Underlying closes below the Buffer Level on the Valuation Date.
oThe U.S. federal tax consequences of an investment in the securities are unclear.
·Risks Relating to the Underlying
oAs a holder of the securities, you will not have voting rights or rights to receive cash dividends or other distributions with respect to the equity securities comprising the Underlying. Your return on the securities will not reflect the return you would realize if you actually owned the equity securities that comprise the Underlying.
oGovernment regulatory action, including legislative acts and executive orders, could result in material changes to the Underlying and could negatively affect your return on the securities.
·Risks Relating to the Issuer
oAs a Swiss bank, Credit Suisse is subject to regulation by governmental agencies, supervisory authorities and self-regulatory organizations in Switzerland. Such regulation is increasingly more extensive and complex and subjects Credit Suisse to risks.
·Risks Relating to Conflicts of Interest

 

oWe and our affiliates play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and as agent of the Issuer of the securities, hedging our obligations under the securities and determining the estimated value of the securities. The agent for this offering, Credit Suisse Securities (USA) LLC (“CSSU”), is our affiliate. In accordance with FINRA Rule 5121, CSSU may not make sales in this offering to any discretionary accounts without the prior written approval of the customer.
·Risks Relating to Estimated Value and Secondary Market Prices of the Securities
oThe securities will be affected by a number of economic, financial, political, regulatory, judicial and other factors that may either offset or magnify each other.
oPrior to maturity, costs such as concessions and hedging may affect the value of the securities.
oCredit Suisse currently estimates the value of each $1,000 principal amount of the securities on the Trade Date will be between $940 and $990 (as determined by reference to our pricing models and the rate we are currently paying to borrow funds through issuance of the securities (our “internal funding rate”)), and the estimated value of the securities on the Trade Date may be less than the price to public.
oIf on the Trade Date the internal funding rate we use in structuring notes such as these securities is lower than the interest rate that is reflected in the yield on our conventional debt securities of similar maturity in the secondary market (our “secondary market credit spreads”), we expect that the economic terms of the securities will generally be less favorable to you than they would have been if our secondary market credit spread had been used in structuring the securities.
oThe securities will not be listed on any securities exchange. Credit Suisse (or its affiliates) intends to offer to purchase the securities in the secondary market but is not required to do so. Many factors, most of which are beyond the control of the Issuer, will influence the value of the securities and the price at which the securities may be purchased or sold in the secondary market. For example, the creditworthiness of the Issuer, including actual or anticipated downgrades to the Issuer’s credit ratings, may be a contributing factor.

      

Important Notice

You may revoke your offer to purchase the securities at any time prior to the time at which we accept such offer on the date the securities are priced. We reserve the right to change the terms of, or reject any offer to purchase the securities prior to their issuance. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.

This document is a summary of the terms of the securities and factors that you should consider before deciding to invest in the securities. Credit Suisse has filed a registration statement (including preliminary pricing supplement, underlying supplement, product supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this offering summary relates. Before you invest, you should read this summary together with the Preliminary Pricing Supplement dated March 7, 2023, Underlying Supplement dated June 18, 2020, Product Supplement No. I–B dated June 18, 2020, Prospectus Supplement dated June 18, 2020 and Prospectus dated June 18, 2020, to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the securities. If the terms described in the applicable preliminary pricing supplement are inconsistent with those described herein, the terms described in the applicable preliminary pricing supplement will control. You may get these documents without cost by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, Credit Suisse, any agent or any dealer participating in this offering will arrange to send you the preliminary pricing supplement, underlying supplement, product supplement, prospectus supplement and prospectus if you so request by calling toll-free 1-800-221-1037.

This fact sheet is a general description of the terms of the offering. Please see the full description in the applicable preliminary pricing supplement: https://www.sec.gov/Archives/edgar/data/1053092/000095010323003768/dp190315_424b2-k2230.htm

You may access the underlying supplement, product supplement, prospectus supplement and prospectus on the SEC website at www.sec.gov or by clicking on the hyperlinks to each of the respective documents incorporated by reference in the preliminary pricing supplement. Please note that “we” and “our” refer to Credit Suisse AG and its affiliates in this document.

 C: 

 C: 

 

 
 

CREDIT SUISSE SECURITIES (USA) LLC

credit-suisse.com

 
 
Copyright © 2023 Credit Suisse Group AG and/or its affiliates. All rights reserved. 
 C: 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘FWP’ Filing    Date    Other Filings
7/8/24
6/28/24
4/7/23
3/31/23
3/30/23
Filed as of:3/8/23FWP
Filed on:3/7/23424B2,  FWP
6/18/20424B2,  6-K,  EFFECT
 List all Filings 


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/07/23  Credit Suisse AG                  424B2                  1:195K                                   Davis Polk & … LLP 01/FA
Top
Filing Submission 0000950103-23-003804   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 11:01:50.2am ET